Login

NRG Energy distinguishes itself with substantial investments in renewable energy, diverging from traditional utility models. 00:10:00

Share On Facebook Share On Twitter

Mauricio Gutierrez, CEO of NRG Energy

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
China's Investment Landscape Amid Global Uncertainty | Yichen Zhang, CEO , CITIC Capital Holding.
00:10:00
With our exceptional investment performances, we have been widely recognized|Nisa Leung, Partners,Qiming Venture
00:10:00
Canaan is a long-time early stage investor|Brent Ahrens,General Partner,Canaan Partners
00:00:00
Pharmaxis welcomes positive interim data for Phase 2 cancer trial - Gary J Phillips B Pharm MBA - Chief Executive Officer, Pharmaxis Ltd
00:10:00
Analyzing the Accuracy of Regular Season Predictions for Playoff Teams: Insights from Digia's Juhana Juppo and Hockey Expert Petteri Sihvonen |Timo Levoranta, PRESIDENT AND CEO of Digia Oyj
00:10:00
Gold and Copper Insights: Wayne Atwell on Current Market Trends
00:10:00
David Kagan is the CEO of Globalstar, highlighted in "Making Leaders."
00:10:00
Buying Trilogy and Doubling Our Reach | Chip Paucek, CEO , 2U Inc.
00:10:00
Moonfare's Co-Investment Strategy: Capitalizing on Private Equity Opportunities
00:10:00
Norwest Minerals: Advancing Copper and Rare Earth Projects in Western Australia
00:10:00
Sunshine Metals Confirms Liontown Feeder Zone with 17m @ 22.1 g/t Au Hit | Dr. Damien Keys, Managing Director, Sunshine Metals Ltd.
00:10:00
Aboriginal Financial Institution Aims to Boost Economic Development in Northern Ontario

© 2017 - Neuhu+